Financhill
Back

The Joint Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
29

JYNT
The Joint

Last Price:
13.92
Seasonality Move:
3.71%
Sell
35

RARE
Ultragenyx Pharmaceutical

Last Price:
38.01
Seasonality Move:
3.65%
Sell
29
The Joint (JYNT) is a Sell

Is The Joint a Buy, Sell or Hold?

  • The current The Joint [JYNT] share price is $13.97. The Score for JYNT is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • JYNT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $37.42. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JYNT Stock Price Chart

What is The Joint's stock price today?

  • The The Joint share price today is $13.97
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JYNT is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $37.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

JYNT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 39.09 Sell
Chaikin Money Flow: -5782 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.43 - 16.73) Sell
Bollinger Bands (100): (10.37 - 15.15) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.58 Sell
Relative Strength Index (14 RSI): 37.74 Sell
Chaikin Money Flow: -836354 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.26 - 42.36) Sell
Bollinger Bands (100): (41.26 - 48.86) Sell

JYNT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.39 Sell
20-day SMA: 15.17 Sell
50-day SMA: 14.5 Sell
200-day SMA: 10.84 Buy
8-day EMA: 14.34 Sell
20-day EMA: 14.83 Sell
50-day EMA: 14.41 Sell
200-day EMA: 12.63 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.11 Sell
20-day SMA: 40.61 Sell
50-day SMA: 42.43 Sell
200-day SMA: 42.45 Sell
8-day EMA: 40.32 Sell
20-day EMA: 40.92 Sell
50-day EMA: 42.29 Sell
200-day EMA: 43.55 Sell

The Joint Earnings Growth & JYNT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.08 per share, a decrease this year of $0.05 per share, and an increase next year of $0.52 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

The Joint Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):